Colorectal Cancer Screening Initiation After Age 50 Years in an Organized Program
Overview
Authors
Affiliations
Introduction: Recent studies report racial disparities among individuals in organized colorectal cancer (CRC) programs; however, there is a paucity of information on CRC screening utilization by race/ethnicity among newly age-eligible adults in such programs.
Methods: This was a retrospective cohort study among Kaiser Permanente Northern California enrollees who turned age 50 years between 2007 and 2012 (N=138,799) and were served by a systemwide outreach and facilitated in-reach screening program based primarily on mailed fecal immunochemical tests to screening-eligible people. Kaplan-Meier and Cox model analyses were used to estimate differences in receipt of CRC screening in 2015-2016.
Results: Cumulative probabilities of CRC screening within 1 and 2 years of subjects' 50th birthday were 51% and 73%, respectively. Relative to non-Hispanic whites, the likelihood of completing any CRC screening was similar in blacks (hazard ratio, 0.98; 95% CI=0.96, 1.00); 5% lower in Hispanics (hazard ratio, 0.95; 95% CI=0.93, 0.96); and 13% higher in Asians (hazard ratio, 1.13; 95% CI=1.11, 1.15) in adjusted analyses. Fecal immunochemical testing was the most common screening modality, representing 86% of all screening initiations. Blacks and Hispanics had lower receipt of fecal immunochemical testing in adjusted analyses.
Conclusions: CRC screening uptake was high among newly screening-eligible adults in an organized CRC screening program, but Hispanics were less likely to initiate screening near age 50 years than non-Hispanic whites, suggesting that cultural and other individual-level barriers not addressed within the program likely contribute. Future studies examining the influences of culturally appropriate and targeted efforts for screening initiation are needed.
Barriers and Facilitators to Colorectal Cancer Screening Among Health Fair Attendees in Utah.
Johnson J, Pauleck S, Williamson A, Pahlkotter M, Brecha F, Ferre N J Prim Care Community Health. 2025; 16:21501319251316659.
PMID: 39976538 PMC: 11843725. DOI: 10.1177/21501319251316659.
Pham L, Clark P, Macdonald G, Thomas J, Dalais C, Fonda A EClinicalMedicine. 2024; 73:102666.
PMID: 38828132 PMC: 11139771. DOI: 10.1016/j.eclinm.2024.102666.
The impact of cumulative colorectal cancer screening delays: A simulation study.
Rutter C, Inadomi J, Maerzluft C J Med Screen. 2021; 29(2):92-98.
PMID: 34894841 PMC: 9217548. DOI: 10.1177/09691413211045103.
Wang A, Lee B, Patel S, Whitaker E, Issaka R, Somsouk M J Med Screen. 2021; 28(4):379-388.
PMID: 33683155 PMC: 8423851. DOI: 10.1177/0969141321997482.
Lee C, Zhu W, Onega T, Henderson L, Kerlikowske K, Sprague B JAMA Netw Open. 2021; 4(2):e2037546.
PMID: 33606032 PMC: 7896194. DOI: 10.1001/jamanetworkopen.2020.37546.